학술논문
High risk of infection in ‘real-world’ patients receiving ibrutinib, idelalisib or venetoclax for mature B-cell leukaemia/lymphoma
Document Type
Article
Author
Source
In: European Journal of Haematology . (European Journal of Haematology, May 2023, 110(5):540-547)
Subject
Language
English
ISSN
16000609
09024441
09024441